Article ; Online: TGR5 agonists for diabetes treatment: a patent review and clinical advancements (2012-present).
Expert opinion on therapeutic patents
2021 Volume 32, Issue 2, Page(s) 191–209
Abstract: Introduction: A cell surface bile acid receptor TGR5 is expressed in various tissues, including the liver, kidney, intestine, and adrenal glands, causing its effect in each tissue to differ. A major role for TGR5 is to maintain blood sugar levels and ... ...
| Abstract | Introduction: A cell surface bile acid receptor TGR5 is expressed in various tissues, including the liver, kidney, intestine, and adrenal glands, causing its effect in each tissue to differ. A major role for TGR5 is to maintain blood sugar levels and increase in energy expenditure. These benefits make it a potential candidate for the treatment of type 2 diabetes, obesity, and other metabolic diseases. Area covered: This paper highlights recent advances in the development of potent steroidal and non-steroidal TGR5 agonists and the peer-reviewed scientific articles that have led to understanding the structure-activity relationship for TGR5 agonists (2012-2020). The review also discusses the clinical progress made by some TGR5 agonists over the past eight years. Expert opinion: In preclinical studies, TGR5 has been found to play a crucial role in GLP-1 secretion and has shown promise for weight loss, anti-diabetic outcomes etc. Semi synthetic and synthetic derivatives can be considered a potential avenue for discovering novel TGR5 agonists. Currently, few TGR5 agonists have reached the clinical trial stage, and, likely, soon novel TGR5 modulator will be discovered with fewer adverse effects. In silico studies can also be performed with various heterocyclic scaffolds to discover selective and safe TGR5 agonists. |
|---|---|
| MeSH term(s) | Bile Acids and Salts ; Diabetes Mellitus, Type 2/drug therapy ; Glucagon-Like Peptide 1/metabolism ; Humans ; Obesity/drug therapy ; Patents as Topic ; Receptors, G-Protein-Coupled/agonists |
| Chemical Substances | Bile Acids and Salts ; Receptors, G-Protein-Coupled ; Glucagon-Like Peptide 1 (89750-14-1) |
| Language | English |
| Publishing date | 2021-12-22 |
| Publishing country | England |
| Document type | Journal Article |
| ZDB-ID | 1186201-4 |
| ISSN | 1744-7674 ; 0962-2594 ; 1354-3776 |
| ISSN (online) | 1744-7674 |
| ISSN | 0962-2594 ; 1354-3776 |
| DOI | 10.1080/13543776.2022.1994551 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.A 3962: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.